Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
about
Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeysGroup II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortexDopamine Receptors and NeurodegenerationThe physiological relevance of functional selectivity in dopamine signallingDopamine inhibits mitochondrial motility in hippocampal neuronsTargeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental healthDopamine receptors - IUPHAR Review 13Methamphetamine increases LPS-mediated expression of IL-8, TNF-α and IL-1β in human macrophages through common signaling pathwaysUnique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in RatsActivation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortexExpression and function of dopamine receptors in the developing medial frontal cortex and striatum of the ratDeletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice.Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategySex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviourRegulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation.Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome.Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptorClozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of AktAntipsychotics activate mTORC1-dependent translation to enhance neuronal morphological complexityInhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in miceSelective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmissionMaladaptive striatal plasticity in L-DOPA-induced dyskinesia.Marked reduction of AKT1 expression and deregulation of AKT1-associated pathways in peripheral blood mononuclear cells of schizophrenia patients.Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models.The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions.Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disordersA dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.The role of iron in learning and memory.New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signalingA signaling pathway AKTing up in schizophreniaAKT kinase activity is required for lithium to modulate mood-related behaviors in mice.Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactionsThe GSK3 signaling pathway is activated by cocaine and is critical for cocaine conditioned reward in miceGlycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in miceRole of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia.
P2860
Q24598398-16509BA2-D6F4-4B3A-8BF3-4E92F3EE1AE8Q24612550-C30E614A-077A-4CD1-83D8-9343B382EC4EQ26783348-AD09463E-3E28-427E-9104-A02BAA18900DQ27027511-C0D9CCAF-4FB4-485A-BF0F-819FE3A6F030Q27300818-47B8D43E-113C-4F1B-9ED5-5F164788414BQ27324174-3044B745-93DA-46F2-86F0-79011D6B8A19Q28118906-DD94FBDC-549E-4A37-A1A3-96EB2C8897F3Q28256783-7D60C2A9-F1F8-4B58-878B-0C821D793128Q28481873-9D01D3DA-561B-4BF2-9E60-44A5C3B6AEAAQ28546441-FC236841-E05C-4F06-85B5-47A86EC97266Q28574586-6ACDADB5-993E-4A97-93B9-7BB8945AD19FQ28583223-38EF34E4-5210-4F13-ABB2-8627A5A0E3FAQ30453635-80574B56-C4D1-4E7A-AEB5-87415B28AFEBQ30456006-42F09389-D61A-4E74-8465-99262FA4AE4AQ30458926-CA712E77-EB4D-432A-A66A-2A4BD82B6AA4Q30470945-719621F8-3AA5-4D17-A1AA-2F42D69A305AQ30522548-0ADCDF5E-0E06-4F71-9D9B-AE84F2C263DBQ33521907-77826BCA-09E5-44E7-AA76-A10E1257BBD7Q33573088-F184B847-04FC-40DF-99F4-76DA79D055ECQ33742774-9D6DE6D1-CDEF-49C5-8F5E-DCE0FC528AC8Q33764262-F87356E6-0029-4746-AE79-B1EC89CF7406Q33777656-B8F82A79-2C39-4569-99D5-B62D6362368BQ34001519-CE081DDC-1351-475A-9C3B-B755A16C235BQ34068943-7311D649-0836-46E2-9B72-3BC5F4A22FDFQ34094008-DD53EBCF-BC45-4548-9A70-00DC874EFBE8Q34185951-F622126C-58D4-4DE9-861B-47A44F189240Q34206314-26F5F56C-CAED-4D29-AF5C-E42EAC489203Q34279073-3FE1C5FB-2501-459B-A757-9BD42DA54F7CQ34391577-57B9ABDD-559B-4B82-B44F-6A90333C67CAQ34490940-DF58ADDC-1276-4E65-AD8E-B0955D72254EQ34508840-3FBEC712-1652-4DA2-A9A6-49DF3BDD5BBAQ34729887-A5397061-B98E-404A-A085-DB0047B0AA4CQ34772251-ADCF382D-4D55-413C-9D10-A9FE6BB45C85Q34780889-27977604-5B1A-4413-BAEC-14FB66D7E5CEQ34988406-6CDF5FFA-9794-4880-B96D-5F56CB096677Q35012574-928B3C74-653A-408F-8542-A9FB6070E7D9Q35049564-D4449D37-CD8D-4B52-913A-491F72A8BA69Q35088414-E3D4A6FD-F423-474E-B0FC-122915EF3841Q35187043-FE6E0EF8-A34C-469B-ADBA-428E3E326DB3Q35197367-24CA5947-0060-4A31-BD70-87DF707675A3
P2860
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
description
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Januar 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/01/24)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/01/24)
@nl
наукова стаття, опублікована в січні 2007
@uk
مقالة علمية (نشرت في 24-1-2007)
@ar
name
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@ast
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@en
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@nl
type
label
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@ast
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@en
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@nl
prefLabel
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@ast
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@en
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@nl
P2093
P50
P921
P3181
P1476
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
@en
P2093
Ali Salahpour
Emanuele Tirotta
Emiliana Borrelli
Marc G Caron
Tatyana D Sotnikova
P304
P3181
P356
10.1523/JNEUROSCI.5074-06.2007
P407
P577
2007-01-24T00:00:00Z